Our Team

[tm_spacer size=”sm:95;lg:113″]
[tm_spacer size=”lg:60″]
[tm_team_member style=”2″ social_networks=”%5B%7B%22icon_fontawesome%22%3A%22fa%20fa-adjust%22%2C%22icon_ion%22%3A%22ion-alert%22%2C%22icon_themify%22%3A%22ti-arrow-up%22%2C%22icon_pe7stroke%22%3A%22pe-7s-album%22%2C%22icon_flat%22%3A%22flaticon-heartbeat%22%7D%5D” name=”Aras Azadian” position=”Chief Executive Officer & Director” desc=”Aras brings extensive senior management experience in the biotechnology and financial sectors including his involvement in several successful start-up companies. In addition to his international experience in corporate development, his diverse roles include his previous position as the president of an investment corporation in the cannabis space and former Chief Operating Officer of an oncology company. Aras holds a Bachelor of Economics degree from York University in Toronto, and an International Masters in Management degree from EADA Business School in Barcelona, Spain.”][tm_team_member style=”2″ social_networks=”%5B%7B%22icon_fontawesome%22%3A%22fa%20fa-adjust%22%2C%22icon_ion%22%3A%22ion-alert%22%2C%22icon_themify%22%3A%22ti-arrow-up%22%2C%22icon_pe7stroke%22%3A%22pe-7s-album%22%2C%22icon_flat%22%3A%22flaticon-heartbeat%22%7D%5D” name=”Setu Purohit” position=”President & Director” desc=”Setu is a lawyer and entrepreneur with experience in complex corporate and legal strategy, contract negotiations, and litigation. He has been involved in the cannabis industry for several years as an advocate for patients’ rights and advising healthcare professionals, licensed cannabis producers, and other corporate and regulatory stakeholders in Canada and abroad. Prior to co-founding Avicanna, Setu operated his own private practice since 2012. Setu holds a Bachelor of Commerce degree from the University of Ottawa and Juris Doctorate (JD) degree from the University of Western Ontario.”][tm_team_member style=”2″ social_networks=”%5B%7B%22icon_fontawesome%22%3A%22fa%20fa-adjust%22%2C%22icon_ion%22%3A%22ion-alert%22%2C%22icon_themify%22%3A%22ti-arrow-up%22%2C%22icon_pe7stroke%22%3A%22pe-7s-album%22%2C%22icon_flat%22%3A%22flaticon-heartbeat%22%7D%5D” name=”Dr. Christine Allen” position=”Chief Scientific Officer” desc=”Dr. Allen is a Full Professor in the Leslie Dan Faculty of Pharmacy at the University of Toronto. Dr. Allen’s research is focused on the design and development of new materials and technologies for the delivery of drugs and contrast agents in addition to synthesis of new polymer materials for nanotechnology-based drug delivery. Dr. Allen’s research has resulted in one hundred thirty peer-reviewed publications on both lipid and polymer-based drug delivery approaches. Dr. Allen has been a Professor at the University of Toronto since 2002. Dr. Allen holds a Ph.D. in Chemistry from McGill University and a B.Sc. in Biochemistry from the University of Ottawa.”][tm_team_member style=”2″ social_networks=”%5B%7B%22icon_fontawesome%22%3A%22fa%20fa-adjust%22%2C%22icon_ion%22%3A%22ion-alert%22%2C%22icon_themify%22%3A%22ti-arrow-up%22%2C%22icon_pe7stroke%22%3A%22pe-7s-album%22%2C%22icon_flat%22%3A%22flaticon-heartbeat%22%7D%5D” name=”Dave Sohi” position=”Chief Financial Officer” desc=”Dave began his career in audit and tax at RSM Richter LLP, a mid-sized accounting and financial advisory firm. Dave received his Chartered Accountant designation in 2008, and following three years in audit and tax he joined the firm’s business advisory practice as a manager. Dave’s main focus in that group’s practice was on mergers and acquisitions and valuation services. While in this group, Dave worked on a number of M&A transactions, advising on both the buy and sell side, and participated in numerous valuation engagements across a variety of industries. In 2010, Dave obtained his Chartered Business Valuator designation, and in 2013 joined Ernst and Young’s Transaction Advisory Practice. Following a year with Ernst and Young, Dave opened his own practice where he provided clients with accounting and advisory services. Dave holds a Bachelor of Commerce degree from Queen’s University.”][tm_team_member style=”2″ social_networks=”%5B%7B%22icon_fontawesome%22%3A%22fa%20fa-adjust%22%2C%22icon_ion%22%3A%22ion-alert%22%2C%22icon_themify%22%3A%22ti-arrow-up%22%2C%22icon_pe7stroke%22%3A%22pe-7s-album%22%2C%22icon_flat%22%3A%22flaticon-heartbeat%22%7D%5D” name=”Arash Moghani” position=”Chief Technical Officer” desc=”Arash began his career at Deloitte as a consultant leading complex strategy and business transformation projects across several sectors globally including banking, technology and healthcare. In 2014, Arash continued his career at the Bank of Montreal, Capital Markets FX Technology department working with diverse teams of stakeholders, gathering business requirements and translating them into comprehensive technology solutions and strategies. Arash holds an Undergraduate Degree from the University of Toronto specializing in Digital Enterprise Management and a Master of Business Administration degree from the Grenoble Graduate School of Business in France.”][tm_team_member style=”2″ social_networks=”%5B%7B%22icon_fontawesome%22%3A%22fa%20fa-adjust%22%2C%22icon_ion%22%3A%22ion-alert%22%2C%22icon_themify%22%3A%22ti-arrow-up%22%2C%22icon_pe7stroke%22%3A%22pe-7s-album%22%2C%22icon_flat%22%3A%22flaticon-heartbeat%22%7D%5D” name=”Lucas Nosiglia” position=”Chief Agricultural Officer” desc=”Lucas has previous experience developing start-up companies in Argentina. In 2013, Lucas started a restaurant called La Causa Nikkei, and operated two locations in Argentina. In 2015, Lucas went on to create a marketing and event agency, Tremending, which focused on providing tailor made experiences for corporate clients. Later, in 2016, Lucas went on to provide business development consulting services for Sanatorios Guemes focused on improving the surgical and pharmaceutical practices of the major medical institution. Lucas holds an undergraduate degree in accounting from the University of Buenos Aires and a Masters in Finance from EADA in Barcelona Spain.”][tm_team_member style=”2″ social_networks=”%5B%7B%22icon_fontawesome%22%3A%22fa%20fa-adjust%22%2C%22icon_ion%22%3A%22ion-alert%22%2C%22icon_themify%22%3A%22ti-arrow-up%22%2C%22icon_pe7stroke%22%3A%22pe-7s-album%22%2C%22icon_flat%22%3A%22flaticon-heartbeat%22%7D%5D” name=”Ivana Maric” position=”EVP Marketing” desc=”Ivana has significant experience within different disciplines of marketing including advertising, strategy, social media management and brand development across several industries. In her former role as Director of Marketing at Ophiuchus Consulting Group, she was responsible for several brand launches in Canada in addition to managing the marketing efforts of several Toronto based start-up companies. Her specialty includes consumer brands with a primary focus on digital marketing and advertising. Ivana has a Bachelor of Commerce degree in Marketing Management from Ryerson University.”][tm_team_member style=”2″ social_networks=”%5B%7B%22icon_fontawesome%22%3A%22fa%20fa-adjust%22%2C%22icon_ion%22%3A%22ion-alert%22%2C%22icon_themify%22%3A%22ti-arrow-up%22%2C%22icon_pe7stroke%22%3A%22pe-7s-album%22%2C%22icon_flat%22%3A%22flaticon-heartbeat%22%7D%5D” name=”Jose Beltran” position=”EVP Corporate Development” desc=”José has over thirty years of pharmaceutical and health industry experience in Latin America. He has been on the executive management team of Pfizer, Abbott, Aspen and Biotoscana and is an expert in marketing & sales management. He has extensive experience working with diverse cultural environments and in leading multi-functional project teams. He holds degrees in Industrial Engineering and Marketing from University of Los Andes in Colombia and a certificate in Program for Leadership Development (PLD24) from Harvard University.”][tm_team_member style=”2″ social_networks=”%5B%7B%22icon_fontawesome%22%3A%22fa%20fa-adjust%22%2C%22icon_ion%22%3A%22ion-alert%22%2C%22icon_themify%22%3A%22ti-arrow-up%22%2C%22icon_pe7stroke%22%3A%22pe-7s-album%22%2C%22icon_flat%22%3A%22flaticon-heartbeat%22%7D%5D” name=”Janeth Mora” position=”EVP Commercialization” desc=”Dr. Mora is an executive within the pharmaceutical industry, with broad and qualified experience in regulatory affairs and marketing across emerging markets. Dr. Mora began her career with the Colombian Regulatory Agency, INVIMA, and then continued in the pharmaceutical industry with Merck & co. She later joined Pfizer Inc. in 1997 where she held different positions of increasing responsibility in regulatory affairs, and then subsequently in marketing for specialty/orphan products. Dr. Mora currently acts as a Strategy and Business Development Advisor for companies in LATAM interested in developing businesses in the region. Janeth also holds degrees in Management, Marketing and Negotiation.”]
[tm_team_member style=”2″ social_networks=”%5B%7B%22icon_fontawesome%22%3A%22fa%20fa-adjust%22%2C%22icon_ion%22%3A%22ion-alert%22%2C%22icon_themify%22%3A%22ti-arrow-up%22%2C%22icon_pe7stroke%22%3A%22pe-7s-album%22%2C%22icon_flat%22%3A%22flaticon-heartbeat%22%7D%5D” name=”Dr. Hance Clarke” position=”MD, PhD” desc=”Dr. Hance Clarke is currently the Director of Pain Services and the Medical Director of the Pain Research Unit at the Toronto General Hospital. He is recognized internationally for his research on novel Transitional Pain Programs, novel Acute Pain Treatment and identifying risk factors associated to opioid use. He is well regarded as one of the top international clinicians researching the efficacy of cannabinoids in pain management. Over the past five years he has authored forty-seven peer reviewed manuscripts.”][tm_team_member style=”2″ social_networks=”%5B%7B%22icon_fontawesome%22%3A%22fa%20fa-adjust%22%2C%22icon_ion%22%3A%22ion-alert%22%2C%22icon_themify%22%3A%22ti-arrow-up%22%2C%22icon_pe7stroke%22%3A%22pe-7s-album%22%2C%22icon_flat%22%3A%22flaticon-heartbeat%22%7D%5D” name=”Dr. Amza Ali” position=”MD, PhD, MBA” desc=”Dr. Amza Ali trained in neurology in both the United Kingdom and in the United States. He has received international recognition for his work in the Caribbean related to advancing the care of patients with epilepsy. The development of a sustainability model in his current doctoral program, at the Henley Business School in the United Kingdom, drives his interest in new pharmacological solutions for epilepsy and other neurological conditions. Dr. Ali holds a Master in Business Administration from the Rotman School of Management, University of Toronto. He is a Fellow of the American Epilepsy Society and the President of the Caribbean Epilepsy Society.”][tm_team_member style=”2″ social_networks=”%5B%7B%22icon_fontawesome%22%3A%22fa%20fa-adjust%22%2C%22icon_ion%22%3A%22ion-alert%22%2C%22icon_themify%22%3A%22ti-arrow-up%22%2C%22icon_pe7stroke%22%3A%22pe-7s-album%22%2C%22icon_flat%22%3A%22flaticon-heartbeat%22%7D%5D” name=”Dr. Mauricio Torres-Pradilla” position=”MD, PhD” desc=”Dr. Mauricio Torres Pradilla is a Dermatologist with a specialization in pediatric dermatology. He has been involved in research on Atopic Dermatitis, Psoriasis, Epidermolysis Bullosa and Hemangiomas in Europe and South America. Mauricio has several publications on these topics, individually and in collaboration. He is currently the Head of Dermatology at Fundación Universitaria de Ciencias de la Salud in Bogota, Colombia and is a Dermatologist at Debra Colombia, dividing his time among three major teaching hospitals and private practice.”][tm_team_member style=”2″ social_networks=”%5B%7B%22icon_fontawesome%22%3A%22fa%20fa-adjust%22%2C%22icon_ion%22%3A%22ion-alert%22%2C%22icon_themify%22%3A%22ti-arrow-up%22%2C%22icon_pe7stroke%22%3A%22pe-7s-album%22%2C%22icon_flat%22%3A%22flaticon-heartbeat%22%7D%5D” name=”Dr. Carlos Maldonado” position=”MD” desc=”Dr. Carlos Enrique Maldonado Muete is a physician, pharmacologist and professor of pharmacology who contributes his experience in biotechnology, pharmacovigilance, clinical studies and knowledge of the medical community and regulatory authorities, as a local and international lecturer. Among other roles, he has participated in medical and regulatory issues related to the approval and commercialization of several new medicines. Dr. Muete has achieved results through his role as a former Medical Director of international pharmaceutical companies and as an external advisor.”][tm_team_member style=”2″ social_networks=”%5B%7B%22icon_fontawesome%22%3A%22fa%20fa-adjust%22%2C%22icon_ion%22%3A%22ion-alert%22%2C%22icon_themify%22%3A%22ti-arrow-up%22%2C%22icon_pe7stroke%22%3A%22pe-7s-album%22%2C%22icon_flat%22%3A%22flaticon-heartbeat%22%7D%5D” name=”Dr. Humberto Reynales” position=”MD, PhD” desc=”Originally from Colombia, Dr. Reynales is an MD in Internal Medicine. He holds a PhD in Epidemology from the University of Sao Paulo, Brazil as well as an MBA from Duke University and has completed a Global Clinical Scholars Research Training Program at Harvard Medical School. He has more than 15 years of experience in the pharmaceutical industry with Merck & Co in the area of Clinical Research. Since 2009, he is the founder and Executive Director of CAIMED, a private clinical research organization with operations in four countries in Latin America, and a leader in clinical trials implementation as well as design and conduct of observational studies in several therapeutic areas.”][tm_team_member style=”2″ social_networks=”%5B%7B%22icon_fontawesome%22%3A%22fa%20fa-adjust%22%2C%22icon_ion%22%3A%22ion-alert%22%2C%22icon_themify%22%3A%22ti-arrow-up%22%2C%22icon_pe7stroke%22%3A%22pe-7s-album%22%2C%22icon_flat%22%3A%22flaticon-heartbeat%22%7D%5D” name=”Dr. Alejandro Berlin” position=”MD, MSC” desc=”Dr. Berlin trained in Chile, Israel and Canada, and currently works as a staff Clinician-Scientist Radiation Oncologist at the Princess Margaret Cancer Centre. His practice focuses in the characterization of malignancies with MRI and molecular imaging, and original applications of combinatorial approaches using systemic agents, stereotactic and MRI-guided ablative treatments. He is particularly interested in the design of innovative clinical trials, translational oncology, and genomic-based biomarker discovery, conveying his clinical and research expertise towards novel treatments for patients with cancer.”][tm_team_member style=”2″ social_networks=”%5B%7B%22icon_fontawesome%22%3A%22fa%20fa-adjust%22%2C%22icon_ion%22%3A%22ion-alert%22%2C%22icon_themify%22%3A%22ti-arrow-up%22%2C%22icon_pe7stroke%22%3A%22pe-7s-album%22%2C%22icon_flat%22%3A%22flaticon-heartbeat%22%7D%5D” name=”Dr. Frantz Le Devedec” position=”PhD – SENIOR VICE PRESIDENT R&D” desc=”Frantz has over 15 years of experience in academic and industrial R&D projects, including material sciences and drug delivery formulations. He is author of over a dozen research papers and patents. His background is in biochemistry, with a PhD in applied polymer chemistry, and expertise in analytical and pharmaceutical sciences.”][tm_team_member style=”2″ social_networks=”%5B%7B%22icon_fontawesome%22%3A%22fa%20fa-adjust%22%2C%22icon_ion%22%3A%22ion-alert%22%2C%22icon_themify%22%3A%22ti-arrow-up%22%2C%22icon_pe7stroke%22%3A%22pe-7s-album%22%2C%22icon_flat%22%3A%22flaticon-heartbeat%22%7D%5D” name=”Dr. Justin Grant” position=”PhD, MBA – Senior Vice President Clinical Development” desc=”Dr. Justin Grant has over fifteen years experience in leading pharmaceutical research in sustained drug release formulations. He held academic appointments at the University of Toronto’s Faculty of Pharmacy and UHN’s Techna Institute for the Advancement of Technology for Health. For over 10 years, he has managed a $50M preclinical cancer research facility (the STTARR Innovation centre) at Princess Margaret Cancer Centre. Justin is currently the Chair of the Scientific Advisory Board for Avicanna.”][tm_team_member style=”2″ social_networks=”%5B%7B%22icon_fontawesome%22%3A%22fa%20fa-adjust%22%2C%22icon_ion%22%3A%22ion-alert%22%2C%22icon_themify%22%3A%22ti-arrow-up%22%2C%22icon_pe7stroke%22%3A%22pe-7s-album%22%2C%22icon_flat%22%3A%22flaticon-heartbeat%22%7D%5D” name=”Dr. Satish Asotra” position=”PhD, MBA – Senior Vice President Scientific Affairs” desc=”Dr. Satish Asotra holds a PhD in Physiology and a Master of Business Administration from the Ivey School of Business. He has experience in driving development, innovation and process improvement of pharmaceutical and healthcare products. Dr. Asotra has lead teams to obtain regulatory approval of pharmaceutical drug products for the U.S.A., Canada and international markets. Dr. Asotra has also authored over ten patent applications and has published thirty-five scientific papers. He is an expert in directing technology transfer processes supporting commercial manufacturing as well as the launching and liaising of marketing activities.”][tm_team_member style=”2″ social_networks=”%5B%7B%22icon_fontawesome%22%3A%22fa%20fa-adjust%22%2C%22icon_ion%22%3A%22ion-alert%22%2C%22icon_themify%22%3A%22ti-arrow-up%22%2C%22icon_pe7stroke%22%3A%22pe-7s-album%22%2C%22icon_flat%22%3A%22flaticon-heartbeat%22%7D%5D” name=”Dr. Akm Hai” position=”PhD, CCHEM – Vice President R&d” desc=”Dr. Hai has twenty-five years of extensive product development experience, including creating formulations, compound synthesis, and analytical method development. Having completed his PhD at Okayama University in Japan, in addition to his Post-Doctoral Fellowship at North Carolina State University, Dr. Hai has experience developing pharmaceutical grade drugs and related delivery systems at GLP (Good Laboratory Practices) and GMP (Good Manufacturing Practices) level of standards with quality testing using instruments such as GC-FID, HPLC-UV, UV-Vis, FT-IR, and GPC-RI.”][tm_team_member style=”2″ social_networks=”%5B%7B%22icon_fontawesome%22%3A%22fa%20fa-adjust%22%2C%22icon_ion%22%3A%22ion-alert%22%2C%22icon_themify%22%3A%22ti-arrow-up%22%2C%22icon_pe7stroke%22%3A%22pe-7s-album%22%2C%22icon_flat%22%3A%22flaticon-heartbeat%22%7D%5D” name=”Samantha Watt” position=”MSC – Vice President Of Scientific Affairs” desc=”Samantha’s experience investigating human physiology and cellular biology has allowed her to develop sophisticated laboratory and project management skills that contribute to Avicanna’s competitive edge in the department of Research and Development. More specifically, Samantha has been published on several different occasions and has also lead various conferences and presentations related to plant gene manipulation and cloning. Samantha received a Master of Science degree in from the University of Guelph.”]
[tm_team_member style=”2″ social_networks=”%5B%7B%22icon_fontawesome%22%3A%22fa%20fa-adjust%22%2C%22icon_ion%22%3A%22ion-alert%22%2C%22icon_themify%22%3A%22ti-arrow-up%22%2C%22icon_pe7stroke%22%3A%22pe-7s-album%22%2C%22icon_flat%22%3A%22flaticon-heartbeat%22%7D%5D” name=”Aras Azadian” position=”MBA – Chief Executive Officer” desc=”Aras brings with him extensive senior management experience in the biotechnology and financial sectors including his involvement in several successful start-up companies. In addition to his international experience in corporate development, his diverse roles include his previous position as the president of an investment corporation in the cannabis space and former Chief Operating Officer of an oncology company. Aras has a Bachelor of Economics degree from York University in Toronto, and a Master of Business Administration degree from EADA Business School in Barcelona, Spain.”][tm_team_member style=”2″ social_networks=”%5B%7B%22icon_fontawesome%22%3A%22fa%20fa-adjust%22%2C%22icon_ion%22%3A%22ion-alert%22%2C%22icon_themify%22%3A%22ti-arrow-up%22%2C%22icon_pe7stroke%22%3A%22pe-7s-album%22%2C%22icon_flat%22%3A%22flaticon-heartbeat%22%7D%5D” name=”Setu Purohit” position=”JD – President” desc=”Setu is a lawyer and entrepreneur with experience in complex corporate and legal strategy, contract negotiations, and litigation. He has been involved in the cannabis industry for several years as an advocate for patients’ rights and advising healthcare professionals, licensed cannabis producers, and other corporate and regulatory stakeholders in Canada and abroad. Setu has received a Bachelor of Commerce degree from the University of Ottawa and Juris Doctorate (JD) degree from the University of Western Ontario. Prior to co-founding Avicanna, Setu operated his own private practice for several years.”][tm_team_member style=”2″ social_networks=”%5B%7B%22icon_fontawesome%22%3A%22fa%20fa-adjust%22%2C%22icon_ion%22%3A%22ion-alert%22%2C%22icon_themify%22%3A%22ti-arrow-up%22%2C%22icon_pe7stroke%22%3A%22pe-7s-album%22%2C%22icon_flat%22%3A%22flaticon-heartbeat%22%7D%5D” name=”Dr. Chandra Panchal” position=”PhD” desc=”Dr. Panchal has been the Chief Executive Officer of Axcelon Biopolymers since 2008, has authored over seventy scientific papers, holds several patents in oncology, diagnostics, biopolymers and microbiology, and is an Adjunct Professor in Chemical and Biochemical Engineering at the University of Western Ontario. Dr. Panchal currently sits on the board of directors of both an oncology company known as Medicenna Therapeutics (MDNA), and Canadian Oil Recovery and Remediation Inc. (CVR) as well as Pure Global Cannabis Inc. (PURE). Dr. Panchal holds a Master of Science degree in Molecular Biology and a Ph.D. in Biochemical Engineering from the University of Western Ontario.”][tm_team_member style=”2″ social_networks=”%5B%7B%22icon_fontawesome%22%3A%22fa%20fa-adjust%22%2C%22icon_ion%22%3A%22ion-alert%22%2C%22icon_themify%22%3A%22ti-arrow-up%22%2C%22icon_pe7stroke%22%3A%22pe-7s-album%22%2C%22icon_flat%22%3A%22flaticon-heartbeat%22%7D%5D” name=”David White” position=”CA, MBA” desc=”Mr. White is a director and chair of audit committees of several Toronto Stock Exchange (“TSX“) and NASDAQ companies. Mr. White has held several senior financial positions with John Labatt Limited, Lawson Marden Group Inc. and Laidlaw Inc. and most recently as Chief Executive Officer of TransCare Inc., a medical transportation company and as President and Chief Executive Officer of Student Transportation of America, a TSX listed company. In addition to sitting on Avicanna’s Board of Directors and chairing the Corporation’s audit committee, Mr. White has also been a corporate director and business consultant for First Call Services, a private holding company and advisory firm, since 2012. Mr. White has been a Canadian Chartered Accountant since 1978 and holds a Master of Business Administration degree from the University of Toronto.”][tm_team_member style=”2″ social_networks=”%5B%7B%22icon_fontawesome%22%3A%22fa%20fa-adjust%22%2C%22icon_ion%22%3A%22ion-alert%22%2C%22icon_themify%22%3A%22ti-arrow-up%22%2C%22icon_pe7stroke%22%3A%22pe-7s-album%22%2C%22icon_flat%22%3A%22flaticon-heartbeat%22%7D%5D” name=”Giancarlo Davilla” position=”CA, MBA” desc=”Giancarlo completed his BSc in Business Administration from Northeastern University, following which he returned to Colombia to work for his family’s business El Grupo Daabon, a company dedicated to the sustainable and organic cultivation and production of industrial scale palm oil, avocados and coffee beans. Giancarlo went on to lead a new branch of El Grupo Daabon which is dedicated to producing private label oils for national distribution in supermarkets across Colombia, and was also the director of sales within Latin American countries. Giancarlo was appointed to Avicanna’s board of directors in October 2018 and sits on Avicanna’ s audit committee.”]
[tm_spacer size=”lg:10″]